Paediatric patients with early-onset atopic dermatitis show higher uveitis risk

News
Article

The study findings support the need to consider ophthalmologic monitoring in children with early-onset atopic dermatitis

A dermatologist examines a child's arm for evidence of atopic dermatitits. Concept image for link between AD and paediatric uveitis. Image credit: ©Kate – stock.adobe.com

Image credit: ©Kate – stock.adobe.com

Taiwanese investigators found in their cohort study that children with early-onset atopic dermatitis had an increased risk of developing uveitis and should be carefully observed to identify that onset.1 The study was led by Yung-Yu Chu, MD, from the Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan.

The researchers retrospectively evaluated the electronic health records of US patients in TriNetX, a collaborative research network, to identify patients with early-onset atopic dermatitis. The study also included matched controls without atopic dermatitis and excluded patients with uveitis before atopic dermatitis was diagnosed. The primary outcome was the hazard ratio (HR) for developing paediatric uveitis in the atopic dermatitis cohort compared with the matched controls, the authors explained.

The search of the health records identified 114,889 patients in the atopic dermatitis and control cohorts; the respective mean patient ages were 0.5 year and 0.6 years.

The results showed that 94 patients with atopic dermatitis developed paediatric uveitis compared with 58 controls (HR, 1.92 [95% confidence interval [CI], 1.38-2.66]).

The results also found that patients in the atopic dermatitis cohort who were not treated with dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals), which is approved to treat the disease (89 of 113, 284 [0.08%] vs 59 of 113, 284 [0.05%]; HR, 1.77 [95% CI, 1.27-2.46]) and patients without autoimmune conditions (80 of 114, 425 [0.07%] vs 61 of 114,425 [0.05%]; HR, 1.52 [95% CI, 1.09-2.12]) also had an increased risk of developing uveitis.

The severity of atopic dermatitis also was an important factor, in that those with severe disease had a higher risk of developing paediatric uveitis compared with those with nonsevereatopic dermatitis (12 of 3,004 [0.40%] vs 97 of 126,482 [0.08%]; HR, 3.64 [95% CI, 2.00-6.66]), Dr Chu and colleagues reported.

Investigators concluded, “This cohort study of children with early-onset AD found an elevated risk of paediatric uveitis compared with matched controls, independent of autoimmune conditions or dupilumab use. These findings support the potential need to consider ophthalmologic monitoring in children with early-onset AD to try to detect and subsequently manage uveitis if it develops.”

They also advised that the relationship between atopic dermatitis and paediatric uveitis may be underexplored and, therefore, warrants large-scale, multicentre studies.

Reference
  1. Chu Y-Y, Sung C-H, Lin Y-S, et al. Risk of developing pediatric uveitis among patients with early-onset atopic dermatitis.JAMA Ophthalmol.Published online April 3, 2025. doi:10.1001/jamaophthalmol.2025.0366

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.